Inhibition of HBV gene expression and replication by stably expressed interferon‐α1 via adeno‐associated viral vectors
Zhi Li(University of Hong Kong), Ming‐Liang He(China National Nuclear Corporation), Joseph J.�Y. Sung(Nanyang Technological University), Ying Peng(Sun Yat-sen University), Yangchao Chen(Guangzhou University of Chinese Medicine), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Qingming Dong(Chinese University of Hong Kong), Marie C.M. Lin(Zhengzhou University), Hsiang‐Fu Kung(Chinese University of Hong Kong), Bo‐Jian Zheng(University of Hong Kong), Chu‐yan Chan(Chinese University of Hong Kong), Hong Yao(Second Affiliated Hospital of Zhejiang University), Jian‐Dong Huang(Sun Yat-sen University), Yan Ma(Gansu Agricultural University)
Cited by 5
Related Papers
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k